Cargando…
Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
Cancer therapeutics can lead to immune equilibrium in which the immune response controls tumor cell expansion without fully eliminating the cancer. The factors involved in this equilibrium remain incompletely understood, especially those that would antagonize the anti-tumor immune response and lead...
Autores principales: | Walsh, Michael J, Ali, Lestat R, Lenehan, Patrick, Kureshi, Courtney T, Kureshi, Rakeeb, Dougan, Michael, Knipe, David M, Dougan, Stephanie K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349916/ https://www.ncbi.nlm.nih.gov/pubmed/37461742 http://dx.doi.org/10.1093/immadv/ltad011 |
Ejemplares similares
-
IFNγ is a central node of cancer immune equilibrium
por: Walsh, Michael J., et al.
Publicado: (2023) -
Correction to: Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
Publicado: (2023) -
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity
por: Kureshi, Rakeeb, et al.
Publicado: (2023) -
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
por: Ali, Lestat R., et al.
Publicado: (2023) -
Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
por: Ali, Lestat R., et al.
Publicado: (2023)